⌘K

Login Start Free

Home/Filings/4/0000899243-21-005080

4//SEC Filing

AGARWAL SUNIL 4

Accession 0000899243-21-005080

CIK 0001770121other

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 5:20 PM ET

Size

5.4 KB

Accession

0000899243-21-005080

Insider Transaction Report

Form 4

Period: 2021-02-03

Sana Biotechnology, Inc.SANA

See Remarks

Transactions

Award
Stock Option (Right to Buy)
2021-02-03+48,000→ 48,000 total
Exercise: $25.00Exp: 2031-02-02→ Common Stock (48,000 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable as to 25% of the underlying shares on February 15, 2022 and in 36 equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Sana Biotechnology, Inc.

CIK 0001770121

Entity typeother

Related Parties

1

filerCIK 0001616640

Filing Metadata

Form type: 4
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 5:20 PM ET
Size: 5.4 KB

View on SEC.gov